The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Meropenem Powder Market Research Report 2024

Global Meropenem Powder Market Research Report 2024

Publishing Date : May, 2022

License Type :
 

Report Code : 1694458

No of Pages : 103

Synopsis
Due to the COVID-19 pandemic, the global Meropenem Powder market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Meropenem Powder market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Meropenem Powder landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Purity Greater than or Equal to 98% accounting for % of the Meropenem Powder global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Skin Infection segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Meropenem Powder include Pfizer, AuroMedics, Sandoz, Amneal Pharmaceuticals, Sumitomo Dainippon Pharma, Ranbaxy Laboratories, Mylan, Sagent Pharmaceuticals and Macleods Pharmaceuticals, etc. In terms of revenue, the global 3 largest players have a % market share of Meropenem Powder in 2021.
This report focuses on Meropenem Powder volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Meropenem Powder market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Meropenem Powder Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Purity Greater than or Equal to 98%
Purity Greater than or Equal to 99%
Segment by Application
Skin Infection
Bacterial Meningitis
Pneumonia
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Pfizer
AuroMedics
Sandoz
Amneal Pharmaceuticals
Sumitomo Dainippon Pharma
Ranbaxy Laboratories
Mylan
Sagent Pharmaceuticals
Macleods Pharmaceuticals
Shenzhen Haibin Pharmaceutical
Chongqing Tiandi Pharmaceutical
PKU HealthCare
United Laboratories
CSPC Group
Zhejiang Hisun Pharmaceutical
Luoxin Pharmaceutical
Index
1 Meropenem Powder Market Overview
1.1 Product Overview and Scope of Meropenem Powder
1.2 Meropenem Powder Segment by Type
1.2.1 Global Meropenem Powder Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Purity Greater than or Equal to 98%
1.2.3 Purity Greater than or Equal to 99%
1.3 Meropenem Powder Segment by Application
1.3.1 Global Meropenem Powder Sales Comparison by Application: (2022-2028)
1.3.2 Skin Infection
1.3.3 Bacterial Meningitis
1.3.4 Pneumonia
1.3.5 Others
1.4 Global Meropenem Powder Market Size Estimates and Forecasts
1.4.1 Global Meropenem Powder Revenue 2017-2028
1.4.2 Global Meropenem Powder Sales 2017-2028
1.4.3 Meropenem Powder Market Size by Region: 2017 Versus 2021 Versus 2028
2 Meropenem Powder Market Competition by Manufacturers
2.1 Global Meropenem Powder Sales Market Share by Manufacturers (2017-2022)
2.2 Global Meropenem Powder Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Meropenem Powder Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Meropenem Powder Manufacturing Sites, Area Served, Product Type
2.5 Meropenem Powder Market Competitive Situation and Trends
2.5.1 Meropenem Powder Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Meropenem Powder Players Market Share by Revenue
2.5.3 Global Meropenem Powder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Meropenem Powder Retrospective Market Scenario by Region
3.1 Global Meropenem Powder Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Meropenem Powder Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Meropenem Powder Market Facts & Figures by Country
3.3.1 North America Meropenem Powder Sales by Country
3.3.2 North America Meropenem Powder Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Meropenem Powder Market Facts & Figures by Country
3.4.1 Europe Meropenem Powder Sales by Country
3.4.2 Europe Meropenem Powder Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Meropenem Powder Market Facts & Figures by Region
3.5.1 Asia Pacific Meropenem Powder Sales by Region
3.5.2 Asia Pacific Meropenem Powder Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Meropenem Powder Market Facts & Figures by Country
3.6.1 Latin America Meropenem Powder Sales by Country
3.6.2 Latin America Meropenem Powder Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Meropenem Powder Market Facts & Figures by Country
3.7.1 Middle East and Africa Meropenem Powder Sales by Country
3.7.2 Middle East and Africa Meropenem Powder Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Meropenem Powder Historic Market Analysis by Type
4.1 Global Meropenem Powder Sales Market Share by Type (2017-2022)
4.2 Global Meropenem Powder Revenue Market Share by Type (2017-2022)
4.3 Global Meropenem Powder Price by Type (2017-2022)
5 Global Meropenem Powder Historic Market Analysis by Application
5.1 Global Meropenem Powder Sales Market Share by Application (2017-2022)
5.2 Global Meropenem Powder Revenue Market Share by Application (2017-2022)
5.3 Global Meropenem Powder Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer Meropenem Powder Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AuroMedics
6.2.1 AuroMedics Corporation Information
6.2.2 AuroMedics Description and Business Overview
6.2.3 AuroMedics Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.2.4 AuroMedics Meropenem Powder Product Portfolio
6.2.5 AuroMedics Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Sandoz Meropenem Powder Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Amneal Pharmaceuticals
6.4.1 Amneal Pharmaceuticals Corporation Information
6.4.2 Amneal Pharmaceuticals Description and Business Overview
6.4.3 Amneal Pharmaceuticals Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Amneal Pharmaceuticals Meropenem Powder Product Portfolio
6.4.5 Amneal Pharmaceuticals Recent Developments/Updates
6.5 Sumitomo Dainippon Pharma
6.5.1 Sumitomo Dainippon Pharma Corporation Information
6.5.2 Sumitomo Dainippon Pharma Description and Business Overview
6.5.3 Sumitomo Dainippon Pharma Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Sumitomo Dainippon Pharma Meropenem Powder Product Portfolio
6.5.5 Sumitomo Dainippon Pharma Recent Developments/Updates
6.6 Ranbaxy Laboratories
6.6.1 Ranbaxy Laboratories Corporation Information
6.6.2 Ranbaxy Laboratories Description and Business Overview
6.6.3 Ranbaxy Laboratories Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Ranbaxy Laboratories Meropenem Powder Product Portfolio
6.6.5 Ranbaxy Laboratories Recent Developments/Updates
6.7 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Mylan Meropenem Powder Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Sagent Pharmaceuticals
6.8.1 Sagent Pharmaceuticals Corporation Information
6.8.2 Sagent Pharmaceuticals Description and Business Overview
6.8.3 Sagent Pharmaceuticals Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Sagent Pharmaceuticals Meropenem Powder Product Portfolio
6.8.5 Sagent Pharmaceuticals Recent Developments/Updates
6.9 Macleods Pharmaceuticals
6.9.1 Macleods Pharmaceuticals Corporation Information
6.9.2 Macleods Pharmaceuticals Description and Business Overview
6.9.3 Macleods Pharmaceuticals Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Macleods Pharmaceuticals Meropenem Powder Product Portfolio
6.9.5 Macleods Pharmaceuticals Recent Developments/Updates
6.10 Shenzhen Haibin Pharmaceutical
6.10.1 Shenzhen Haibin Pharmaceutical Corporation Information
6.10.2 Shenzhen Haibin Pharmaceutical Description and Business Overview
6.10.3 Shenzhen Haibin Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Shenzhen Haibin Pharmaceutical Meropenem Powder Product Portfolio
6.10.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
6.11 Chongqing Tiandi Pharmaceutical
6.11.1 Chongqing Tiandi Pharmaceutical Corporation Information
6.11.2 Chongqing Tiandi Pharmaceutical Meropenem Powder Description and Business Overview
6.11.3 Chongqing Tiandi Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Chongqing Tiandi Pharmaceutical Meropenem Powder Product Portfolio
6.11.5 Chongqing Tiandi Pharmaceutical Recent Developments/Updates
6.12 PKU HealthCare
6.12.1 PKU HealthCare Corporation Information
6.12.2 PKU HealthCare Meropenem Powder Description and Business Overview
6.12.3 PKU HealthCare Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.12.4 PKU HealthCare Meropenem Powder Product Portfolio
6.12.5 PKU HealthCare Recent Developments/Updates
6.13 United Laboratories
6.13.1 United Laboratories Corporation Information
6.13.2 United Laboratories Meropenem Powder Description and Business Overview
6.13.3 United Laboratories Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.13.4 United Laboratories Meropenem Powder Product Portfolio
6.13.5 United Laboratories Recent Developments/Updates
6.14 CSPC Group
6.14.1 CSPC Group Corporation Information
6.14.2 CSPC Group Meropenem Powder Description and Business Overview
6.14.3 CSPC Group Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.14.4 CSPC Group Meropenem Powder Product Portfolio
6.14.5 CSPC Group Recent Developments/Updates
6.15 Zhejiang Hisun Pharmaceutical
6.15.1 Zhejiang Hisun Pharmaceutical Corporation Information
6.15.2 Zhejiang Hisun Pharmaceutical Meropenem Powder Description and Business Overview
6.15.3 Zhejiang Hisun Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Zhejiang Hisun Pharmaceutical Meropenem Powder Product Portfolio
6.15.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.16 Luoxin Pharmaceutical
6.16.1 Luoxin Pharmaceutical Corporation Information
6.16.2 Luoxin Pharmaceutical Meropenem Powder Description and Business Overview
6.16.3 Luoxin Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Luoxin Pharmaceutical Meropenem Powder Product Portfolio
6.16.5 Luoxin Pharmaceutical Recent Developments/Updates
7 Meropenem Powder Manufacturing Cost Analysis
7.1 Meropenem Powder Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Meropenem Powder
7.4 Meropenem Powder Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Meropenem Powder Distributors List
8.3 Meropenem Powder Customers
9 Meropenem Powder Market Dynamics
9.1 Meropenem Powder Industry Trends
9.2 Meropenem Powder Market Drivers
9.3 Meropenem Powder Market Challenges
9.4 Meropenem Powder Market Restraints
10 Global Market Forecast
10.1 Meropenem Powder Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Meropenem Powder by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Meropenem Powder by Type (2023-2028)
10.2 Meropenem Powder Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Meropenem Powder by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Meropenem Powder by Application (2023-2028)
10.3 Meropenem Powder Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Meropenem Powder by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Meropenem Powder by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Meropenem Powder Sales Growth Rate Comparison by Type (2022-2028) & (Ton) & (US$ Million)
Table 2. Global Meropenem Powder Sales Growth Rate Comparison by Application (2022-2028) & (Ton) & (US$ Million)
Table 3. Global Meropenem Powder Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Meropenem Powder Market Competitive Situation by Manufacturers in 2021
Table 5. Global Meropenem Powder Sales (Ton) of Key Manufacturers (2017-2022)
Table 6. Global Meropenem Powder Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Meropenem Powder Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Meropenem Powder Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Meropenem Powder Average Price (US$/Kg) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Meropenem Powder Manufacturing Sites and Area Served
Table 11. Manufacturers Meropenem Powder Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Meropenem Powder by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meropenem Powder as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Meropenem Powder Sales by Region (2017-2022) & (Ton)
Table 16. Global Meropenem Powder Sales Market Share by Region (2017-2022)
Table 17. Global Meropenem Powder Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Meropenem Powder Revenue Market Share by Region (2017-2022)
Table 19. North America Meropenem Powder Sales by Country (2017-2022) & (Ton)
Table 20. North America Meropenem Powder Sales Market Share by Country (2017-2022)
Table 21. North America Meropenem Powder Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Meropenem Powder Revenue Market Share by Country (2017-2022)
Table 23. Europe Meropenem Powder Sales by Country (2017-2022) & (Ton)
Table 24. Europe Meropenem Powder Sales Market Share by Country (2017-2022)
Table 25. Europe Meropenem Powder Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Meropenem Powder Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Meropenem Powder Sales by Region (2017-2022) & (Ton)
Table 28. Asia Pacific Meropenem Powder Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Meropenem Powder Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Meropenem Powder Revenue Market Share by Region (2017-2022)
Table 31. Latin America Meropenem Powder Sales by Country (2017-2022) & (Ton)
Table 32. Latin America Meropenem Powder Sales Market Share by Country (2017-2022)
Table 33. Latin America Meropenem Powder Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Meropenem Powder Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Meropenem Powder Sales by Country (2017-2022) & (Ton)
Table 36. Middle East and Africa Meropenem Powder Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Meropenem Powder Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Meropenem Powder Revenue Market Share by Country (2017-2022)
Table 39. Global Meropenem Powder Sales by Type (2017-2022) & (Ton)
Table 40. Global Meropenem Powder Sales Market Share by Type (2017-2022)
Table 41. Global Meropenem Powder Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Meropenem Powder Revenue Share by Type (2017-2022)
Table 43. Global Meropenem Powder Price by Type (2017-2022) & (US$/Kg)
Table 44. Global Meropenem Powder Sales (Ton) by Application (2017-2022)
Table 45. Global Meropenem Powder Sales Market Share by Application (2017-2022)
Table 46. Global Meropenem Powder Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Meropenem Powder Revenue Share by Application (2017-2022)
Table 48. Global Meropenem Powder Price by Application (2017-2022) & (US$/Kg)
Table 49. Pfizer Corporation Information
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 52. Pfizer Meropenem Powder Product
Table 53. Pfizer Recent Developments/Updates
Table 54. AuroMedics Corporation Information
Table 55. AuroMedics Description and Business Overview
Table 56. AuroMedics Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 57. AuroMedics Meropenem Powder Product
Table 58. AuroMedics Recent Developments/Updates
Table 59. Sandoz Corporation Information
Table 60. Sandoz Description and Business Overview
Table 61. Sandoz Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 62. Sandoz Meropenem Powder Product
Table 63. Sandoz Recent Developments/Updates
Table 64. Amneal Pharmaceuticals Corporation Information
Table 65. Amneal Pharmaceuticals Description and Business Overview
Table 66. Amneal Pharmaceuticals Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 67. Amneal Pharmaceuticals Meropenem Powder Product
Table 68. Amneal Pharmaceuticals Recent Developments/Updates
Table 69. Sumitomo Dainippon Pharma Corporation Information
Table 70. Sumitomo Dainippon Pharma Description and Business Overview
Table 71. Sumitomo Dainippon Pharma Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 72. Sumitomo Dainippon Pharma Meropenem Powder Product
Table 73. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 74. Ranbaxy Laboratories Corporation Information
Table 75. Ranbaxy Laboratories Description and Business Overview
Table 76. Ranbaxy Laboratories Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 77. Ranbaxy Laboratories Meropenem Powder Product
Table 78. Ranbaxy Laboratories Recent Developments/Updates
Table 79. Mylan Corporation Information
Table 80. Mylan Description and Business Overview
Table 81. Mylan Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 82. Mylan Meropenem Powder Product
Table 83. Mylan Recent Developments/Updates
Table 84. Sagent Pharmaceuticals Corporation Information
Table 85. Sagent Pharmaceuticals Description and Business Overview
Table 86. Sagent Pharmaceuticals Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 87. Sagent Pharmaceuticals Meropenem Powder Product
Table 88. Sagent Pharmaceuticals Recent Developments/Updates
Table 89. Macleods Pharmaceuticals Corporation Information
Table 90. Macleods Pharmaceuticals Description and Business Overview
Table 91. Macleods Pharmaceuticals Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 92. Macleods Pharmaceuticals Meropenem Powder Product
Table 93. Macleods Pharmaceuticals Recent Developments/Updates
Table 94. Shenzhen Haibin Pharmaceutical Corporation Information
Table 95. Shenzhen Haibin Pharmaceutical Description and Business Overview
Table 96. Shenzhen Haibin Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 97. Shenzhen Haibin Pharmaceutical Meropenem Powder Product
Table 98. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 99. Chongqing Tiandi Pharmaceutical Corporation Information
Table 100. Chongqing Tiandi Pharmaceutical Description and Business Overview
Table 101. Chongqing Tiandi Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 102. Chongqing Tiandi Pharmaceutical Meropenem Powder Product
Table 103. Chongqing Tiandi Pharmaceutical Recent Developments/Updates
Table 104. PKU HealthCare Corporation Information
Table 105. PKU HealthCare Description and Business Overview
Table 106. PKU HealthCare Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 107. PKU HealthCare Meropenem Powder Product
Table 108. PKU HealthCare Recent Developments/Updates
Table 109. United Laboratories Corporation Information
Table 110. United Laboratories Description and Business Overview
Table 111. United Laboratories Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 112. United Laboratories Meropenem Powder Product
Table 113. United Laboratories Recent Developments/Updates
Table 114. CSPC Group Corporation Information
Table 115. CSPC Group Description and Business Overview
Table 116. CSPC Group Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 117. CSPC Group Meropenem Powder Product
Table 118. CSPC Group Recent Developments/Updates
Table 119. Zhejiang Hisun Pharmaceutical Corporation Information
Table 120. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 121. Zhejiang Hisun Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 122. Zhejiang Hisun Pharmaceutical Meropenem Powder Product
Table 123. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 124. Luoxin Pharmaceutical Corporation Information
Table 125. Luoxin Pharmaceutical Description and Business Overview
Table 126. Luoxin Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 127. Luoxin Pharmaceutical Meropenem Powder Product
Table 128. Luoxin Pharmaceutical Recent Developments/Updates
Table 129. Production Base and Market Concentration Rate of Raw Material
Table 130. Key Suppliers of Raw Materials
Table 131. Meropenem Powder Distributors List
Table 132. Meropenem Powder Customers List
Table 133. Meropenem Powder Market Trends
Table 134. Meropenem Powder Market Drivers
Table 135. Meropenem Powder Market Challenges
Table 136. Meropenem Powder Market Restraints
Table 137. Global Meropenem Powder Sales Forecast by Type (2023-2028) & (Ton)
Table 138. Global Meropenem Powder Sales Market Share Forecast by Type (2023-2028)
Table 139. Global Meropenem Powder Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 140. Global Meropenem Powder Revenue Market Share Forecast by Type (2023-2028)
Table 141. Global Meropenem Powder Sales Forecast by Application (2023-2028) & (Ton)
Table 142. Global Meropenem Powder Sales Market Share Forecast by Application (2023-2028)
Table 143. Global Meropenem Powder Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 144. Global Meropenem Powder Revenue Market Share Forecast by Application (2023-2028)
Table 145. Global Meropenem Powder Sales Forecast by Region (2023-2028) & (Ton)
Table 146. Global Meropenem Powder Sales Market Share Forecast by Region (2023-2028)
Table 147. Global Meropenem Powder Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 148. Global Meropenem Powder Revenue Market Share Forecast by Region (2023-2028)
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Meropenem Powder
Figure 2. Global Meropenem Powder Market Share by Type in 2021 & 2028
Figure 3. Purity Greater than or Equal to 98% Product Picture
Figure 4. Purity Greater than or Equal to 99% Product Picture
Figure 5. Global Meropenem Powder Market Share by Application in 2021 & 2028
Figure 6. Skin Infection
Figure 7. Bacterial Meningitis
Figure 8. Pneumonia
Figure 9. Others
Figure 10. Global Meropenem Powder Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Meropenem Powder Market Size (2017-2028) & (US$ Million)
Figure 12. Global Meropenem Powder Sales (2017-2028) & (Ton)
Figure 13. Meropenem Powder Sales Share by Manufacturers in 2021
Figure 14. Global Meropenem Powder Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Meropenem Powder Players: Market Share by Revenue in 2021
Figure 16. Meropenem Powder Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Meropenem Powder Sales Market Share by Region (2017-2022)
Figure 18. Global Meropenem Powder Sales Market Share by Region in 2021
Figure 19. Global Meropenem Powder Revenue Market Share by Region (2017-2022)
Figure 20. Global Meropenem Powder Revenue Market Share by Region in 2021
Figure 21. United States Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Taiwan Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Meropenem Powder Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Meropenem Powder by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Meropenem Powder
Figure 45. Manufacturing Process Analysis of Meropenem Powder
Figure 46. Meropenem Powder Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’